Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Sergio Carlos Nahas, Edwaldo Eduardo Camargo, Caio Sergio Rizkallah Nahas
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Staging and follow-up of gastrointestinal tumors with PET/CT
10.1007/s00261-005-0031-3 · 2006
Positron emission tomography: clinical applications in oncology
10.1586/14737140.5.6.1079 · 2005
FDG accumulation and tumor biology
10.1016/s0969-8051(97)00226-6 · 1998
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice
1999
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
10.1016/s0959-8049(99)00229-4 · 1999
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings
10.1148/radiology.206.3.9494497 · 1998
Preoperative evaluation by whole-body 18Ffluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer
2000
Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making
2003
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer
10.1245/aso.2006.04.042 · 2006
Does positron emission tomography change management in primary rectal cancer?
10.1007/s10350-003-0089-3 · 2004
Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma
2003
Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology
10.1001/jama.290.24.3199 · 2003
Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging
10.1200/jco.2005.01.4340 · 2005
Cancer statistics, 2006
10.3322/canjclin.56.2.106 · 2006
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
10.1016/s0002-9610(99)00187-7 · 1999
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study
2002
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases
10.1002/cncr.21569 · 2005
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
10.1097/01.sla.0000146145.69835.c5 · 2004
An audit of fusion CT-PET in the management of colorectal liver metastases
10.1016/j.ejso.2006.02.003 · 2006
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer
2005
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases
10.1089/cbr.2005.20.450 · 2005
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
10.1200/jco.2005.04.4222 · 2005
Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
10.1097/00000658-199803000-00001 · 1998
False positive F-18 fluorodeoxyglucose combined PET/CT scans from suture granuloma and chronic inflammation: report of two cases and review of literature
10.47102/annals-acadmedsg.v34n7p457 · 2005
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography
10.1007/bf02303744 · 1997
Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup
10.1067/msy.2001.116919 · 2001
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients
10.1016/s1072-7515(03)00337-5 · 2003
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
10.1007/bf02238010 · 2000
FDG-PET improves the management of patients with suspected recurrence of colorectal cancer
10.1097/00006231-200210000-00007 · 2002
Positron emission tomography affects surgical management in recurrent colorectal cancer patients
10.1245/aso.2003.05.006 · 2003
10.1007/s10434-001-0779-9
10.1007/s10434-001-0779-9 · 2001
Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection
10.1148/radiol.2323031065 · 2004
Preoperative versus postoperative chemoradiotherapy for rectal cancer
10.1056/nejmoa040694 · 2004
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography
10.1007/bf02237238 · 2000
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology
10.1007/s00259-003-1453-1 · 2004
Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response
10.1200/jco.2005.23.16_suppl.3612 · 2005
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining long term outcomes of rectal cancer
10.1016/j.jamcollsurg.2004.02.024 · 2004
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation
10.1016/j.ijrobp.2003.09.058 · 2004
No additional external references are available.